Quinidine gluconate
Quinidine Gluconate is a prescription medication available as an extended-release tablet (324 mg) for oral use. It acts as an antiarrhythmic drug to help regulate heart rhythm, particularly in cases of atrial fibrillation or ventricular arrhythmias. Manufactured by Sun Pharmaceutical Industries, Inc., it's a generic version approved under ANDA 089338. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Quinidine Gluconate is a prescription medication available as an extended-release tablet (324 mg) for oral use. It acts as an antiarrhythmic drug to help regulate heart rhythm, particularly in cases of atrial fibrillation or ventricular arrhythmias. Manufactured by Sun Pharmaceutical Industries, Inc., it's a generic version approved under ANDA 089338. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Quinidine gluconate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Quinidine gluconate — ANDA 089338 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089338"
}
]
|
| identifier | ANDA089338 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"health-care",
"pharmaceuticals",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Quinidine gluconate |
